Amanote Research
Register
Sign In
Pss18 - Treatment Costs of Atopic Dermatitis in Korean Adults According to Disease Severity
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2518
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
S. Ha
Y. Yim
D. An
E. Lee
Publisher
Elsevier BV
Related search
Atopic Dermatitis in Older Adults: A Review of Treatment Options
Drugs and Aging
Gerontology
Geriatrics
Pharmacology
The Prevalence of Atopic Dermatitis in Korean Children
Allergy, Asthma and Immunology Research
Immunology
Pulmonary
Allergy
Respiratory Medicine
Dupilumab Versus Cyclosporine for Treatment of Moderate-To-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index
Acta Dermato-Venereologica
Dermatology
Medicine
Efficacy and Safety of Dupilumab for the Treatment of Moderate-To-Severe Atopic Dermatitis in Adults
Oncotarget
Oncology
The Costs of Illness of Atopic Dermatitis in South Korea
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Diagnosis and Treatment of Atopic Dermatitis.
Nippon Ika Daigaku Zasshi
Future Trends in the Treatment of Atopic Dermatitis
Immunological Medicine
Allergy
Immunology
Type of Food Allergen Is Associated With Atopic Dermatitis Severity
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Narrow-Band UVB Treatment in Atopic Dermatitis
Acta Dermato-Venereologica
Dermatology
Medicine
